phase readout
saveNCT02650401: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
ACTIVE_NOT_RECRUITINGupdated 11d ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Solid Tumors, CNS Tumors
view source ↗
comments(0)
5-min edit window · permanent after that